Orphan drug clinical development
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical)
Reference24 articles.
1. Orphan drug designations and approvals;Food and Drug Administration,2019
2. Clinical development success rates for investigational drugs;Hay;Nat Biotechnol,2014
3. Success rates for product development strategies in new drug development;Dahlin;J Clin Pharm Ther,2016
4. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival;Morgan;Drug Discov Today,2012
5. Impact of a five-dimensional framework on R&D productivity at AstraZeneca;Morgan;Nat Rev Drug Discov,2018
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Trends in orphan medicinal products approvals in the European Union between 2010–2022;Orphanet Journal of Rare Diseases;2024-02-27
2. A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases;Scientific Reports;2023-11-08
3. Designs used in published therapeutic studies of rare superficial vascular anomalies: a systematic literature search;BMC Medical Research Methodology;2023-08-30
4. A novelin silicoscaffold-hopping method for drug repositioning in rare and intractable diseases;2023-07-04
5. Future prospects for human genetics and genomics in drug discovery;Current Opinion in Structural Biology;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3